09/15/2026
ππͺππππ‘ππ£π πππ©ππ: Updated consensus guidance from the Infectious Diseases Society of America (IDSA) on the treatment of antimicrobial-resistant gram-negative infections incorporates several newly approved agents.
"The new recommendation reinforces my practice: In patients with severe S. maltophilia infection, I typically avoid trimethoprimβsulfamethoxazole and instead choose cefiderocol, aztreonamβavibactam, or a new-generation tetracycline," writes George Sakoulas, MD.